Is eLife Indexed in PubMed? Yes, and MEDLINE Is Active

This query is unusually important for eLife because many authors are not really asking whether the journal is visible. They are asking whether the publication model changes legitimacy, retrievability, or citation behavior.

Strong eLife papers often want:

• broad biology discoverability
• easy retrieval for readers outside one exact subfield
• visibility that does not depend on the reader understanding the journal’s publication model first
• open full-text access through normal biomedical search workflows

PubMed and PMC help with exactly that.

For this journal, all three fields matter:

• PubMed means the paper is discoverable in the main biomedical search system.
• MEDLINE means the journal is actively inside the curated NLM journal index.
• PMC matters because full-text accessibility is part of the journal’s actual publishing model and reader experience.

That combination is why the paper can still travel through normal literature workflows even if the author is skeptical about other parts of the eLife strategy.

This page answers the discoverability question. It does not answer whether eLife is the right strategic target for your paper.

Indexing tells you the paper will be visible and retrievable. It does not tell you whether the reviewed-preprint model matches your field norms, career incentives, or publishing goals.

That is why the better next reads are:

• Is eLife a good journal?
• eLife submission guide
• eLife submission process
• eLife acceptance rate

Yes, eLife is indexed in PubMed and currently indexed for MEDLINE, and the NLM record also shows PMC coverage. If your question is whether a published paper will be visible in the main biomedical search workflow, the answer is yes.

If your real question is whether the eLife model is strategically right for this paper, that is a separate judgment. A free Manusights scan is the best next step if you want that call before submission.